TIDMACRL

RNS Number : 8784I

Accrol Group Holdings PLC

17 December 2020

17 December 2020

ACCROL GROUP HOLDINGS PLC

("Accrol", the "Company" or the "Group")

AIM: ACRL

NOTICE OF HALF YEAR RESULTS

Accrol Group, one of the UK's leading independent tissue converters, announces that it will release its Half Year Results for the six months to 31 October 2020 on Tuesday, 12 January 2021.

An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications, see contact details below.

A webinar presentation for retail investors will also be held as part of the results roadshow. Details of this event will be announced in due course.

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Jordan Warburton                  Tel: +44 (0) 161 831 1512 
Dominic King / John Goold                    Tel: +44 (0) 203 829 5000 
 
Liberum Capital Limited (Joint Broker)       Tel: +44 (0) 20 3100 2222 
Clayton Bush / Edward Thomas 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 078 
Keeley Clarke                                Tel: +44 (0) 7967 816 525 
Llew Angus                                   Tel: +44 (0) 7407 023 147 
                                              accrolpr@belvederepr.com 
 

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP1.7bn UK retail tissue market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORFQLFFBLLEFBF

(END) Dow Jones Newswires

December 17, 2020 02:00 ET (07:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Accrol Charts.